🇰🇷 Relenza in South Korea

Relenza (ZANAMIVIR) regulatory status in South Korea.

Marketing authorisation

MFDS

  • Status: likely_approved

Relenza in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Infectious Disease approved in South Korea

Frequently asked questions

Is Relenza approved in South Korea?

Yes. MFDS has authorised it.

Who is the marketing authorisation holder for Relenza in South Korea?

GSK is the originator. The local marketing authorisation holder may differ — check the official source linked above.